TheProfitWatch

ATRA - Atara Biotherapeutics, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
14.5 -0.8 (-5.52%) --- --- -0.34 (-2.42%) 0.0 (0.0%) 0.36 (2.7%) --- 0.0 (0.0%)

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
0.2
Diluted EPS:
0.19
Basic P/E:
68.5
Diluted P/E:
72.1053
RSI(14) 1m:
14.29
VWAP:
13.72
RVol:

Events

Period Kind Movement Occurred At

Related News